did tirzepatide get discontinued Compounded (GLP-1/GIP) why is tirzepatide being discontinued

was a randomized, double-blind, placebo-controlled, phase 3 study that evaluated the efficacy and safety of a phentermine-topiramate combination in 2,487 adults aged 18-70 years with a BMI of 27-45 kg/m and at least two weight-related comorbidities such as hypertension, dyslipidemia, or diabetes

1 Non-communicable Diseases Research Unit, South African Medical Research Council, Durban, South Africa, 2 Inkosi Albert Luthuli Central Hospital (IALCH), Durban, South Africa, 3 Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa, 4 Non-communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa

Other factors known to contribute to gastritis include injury, excess alcohol intake and the use of certain pain killers

Working closely with the patient and the prescriber, compounding gives the pharmacist the means to customize medication to meet the individual needs of each patient

PMDA Q2

When a person no longer qualifies for Health First Colorado or CHP+ coverage, it is typically allowed for that person to join an employers plan